Ubrelvy Tablet
Product Images NDC 0023-6498

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Ubrelvy (NDC 0023-6498). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Allergan, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

The Following Structural Formula For Ubrelvy Is Ubrogepant, A Calcitonin Gene-related Peptide (cgrp) Receptor Antagonist. The Chemical Name Of Ubrogepant Is (3's)-n-((3s,5s,6r)-6-methyl-2-oxo-5-phenyl-1-(2,2,2-trifluoroethyl)piperidin-3-yl)-2'-oxo-1',2',5,7-tetrahydrospiro[cyclopenta[b]pyridine-6,3'-pyrrolo[2,3-b]pyridine]-3-carboxamide. (Ubrelvy 01)

Chemical structure diagram of ubrogepant, the active ingredient in UBRELVY tablets. The diagram displays atom and bond connectivity characteristic of the molecular formula without additional annotations.*

FDA Label Image

Figure 1: Percentage Of Patients Achieving Pain Freedom Within 2 Hours In Pooled Studies 1 And 2 (Ubrelvy 02)

A line graph illustrating the percent of patients achieving pain freedom over time up to 2 hours after dosing with UBRELVY tablets at 50 mg and 100 mg strengths compared to placebo. The x-axis represents time in hours from dose, and the y-axis shows the percentage achieving pain freedom, with both doses generally showing higher percentages than placebo over time.*

FDA Label Image

Figure 2: Percentage Of Patients Achieving Mbs Freedom Within 2 Hours In Pooled Studies 1 And 2 (Ubrelvy 03)

A line graph showing the percent of subjects achieving MBS freedom over time from dose. The x-axis represents time in hours (0 to 2 hours), and the y-axis shows percent achieving freedom (0% to 100%). Three lines compare UBRELVY 100 mg, UBRELVY 50 mg, and placebo, with UBRELVY doses showing higher percentages than placebo over time.*

FDA Label Image

Allergan (Ubrelvy 05)

FDA Label Image

Ndc 0023-6498-02ubrelvy(ubrogepant) Tablet50 mgrx Onlycontains 1 Tablet (Ubrelvy 06)

UBRELVY (ubrogepant) 50 mg oral tablet label. The front shows the product name, generic name, strength, and quantity of 1 tablet. The back includes dosage form details, manufacturer Forest Laboratories, distributor Allergan USA, storage instructions, and a barcode.*

FDA Label Image

Ndc 0023-6498-02ubrelvy(ubrogepant) Tablet50 mgrx Onlycontains 1 Tablet (Ubrelvy 07)

Flat packaging label for UBRELVY tablets, containing 50 mg of the active ingredient ubrogepant. The label shows the product name with the generic name in parentheses, a blue wave design, and states it contains 10 tablets. It is labeled Rx only and is distributed by Allergan, Inc.*

FDA Label Image

Ndc 0023-6498-10ubrelvy(ubrogepant) Tablets50 mgrx Onlycontains 10 Tablets (Ubrelvy 08)

Packaging label for UBRELVY (ubrogepant) 50 mg oral tablets by Allergan, Inc. The label shows a carton layout with the product name, generic name, strength (50 mg), dosage form (tablets), package quantity (15 tablets), and a note indicating 'Rx Only.' The label includes branding elements and a barcode.*

FDA Label Image

Ndc 0023-6498-16ubrelvy(ubrogepant) Tablets50 mgrx Onlycontains 16 Tablets (Ubrelvy 09)

Packaging label for UBRELVY (ubrogepant) tablets, 50 mg strength. The label indicates it contains 30 tablets and is marked Rx Only. The design includes the brand name and generic name with a blue wave graphic. The labeler is Allergan, Inc., with manufacturing in Dublin, Ireland. Storage instructions and barcode are also visible.*

FDA Label Image

Ndc 0023-6498-30ubrelvy(ubrogepant) Tablets50 mgrx Onlycontains 30 Tablets (Ubrelvy 0a)

The image shows the front and back of the UBRELVY 100 mg tablet label. The front displays the brand name UBRELVY with the generic name ubrogepant, dosage strength of 100 mg, and indicates one tablet per unit. The back label includes storage instructions, manufacturer and distributor information, a barcode, lot number, and expiration date area. The labeler is Allergan, Inc.*

FDA Label Image

Ndc 0023-6501-02ubrelvy(ubrogepant) Tablet100 mgrx Onlycontains 1 Tablet (Ubrelvy 0b)

Flat packaging label for UBRELVY 100 mg oral tablets containing ubrogepant, manufactured by Allergan, Inc. The label shows the product name, strength, dosage form, quantity of 10 tablets, and includes a barcode and serialization information. The design features green and white areas with black text.*

FDA Label Image

Ndc 0023-6501-02ubrelvy(ubrogepant) Tablet100 mgrx Onlycontains 1 Tablet (Ubrelvy 0c)

Packaging label for UBRELVY 100 mg tablet by Allergan, Inc. The label is for oral ubrogepant tablets in a tablet form, showing product name, strength, and quantity details. The design includes the UBRELVY logo with teal and pink color accents, and mentions the product contains 8 tablets in the package.*

FDA Label Image

Ndc 0023-6501-10ubrelvy(ubrogepant) Tablets100 mgrx Onlycontains 10 Tablets (Ubrelvy 0d)

Packaging label for UBRELVY (ubrogepant) tablets 100 mg by Allergan, Inc. The label shows the product name, strength, dosage form, and information including 30 tablets per container, Rx only, and storage conditions. The design includes a green section and barcode with allergen and manufacturing details.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.